Thylakoids are plant membranes concentrated into oral spinach supplements for appetite and weight management. Short-term hunger and fullness are the clearest benefits; weight, cholesterol, and glucose findings are inconsistent. For adults with strong nutrition and exercise habits, possible appetite support is the main value. Longer lifespan and disease prevention remain unproven. Long-term safety and interactions are uncertain; reduced intake may compromise nutrition and muscle. (Full Review)
| Marker | Target | Why |
|---|---|---|
| Body weight and waist | No established thylakoid-specific target; baseline and intended change | Assess sustained effect |
| Fasting glucose | 80–89 mg/dL (Kresser’s practitioner preference; not a universal treatment target) | Detect glucose change |
| HbA1c | 4.6–5.3% (Kresser’s practitioner range) | Longer-term glucose context; average blood glucose |
| Lipid panel | No established extract-specific optimal range; individual risk-based targets | Assess lipid signal |
| Nutrient status | No established supplement-specific target; baseline and restricted intake | Detect nutritional compromise; testing by clinical context |
| Warfarin clotting test | No established thylakoid-specific target; prescribed therapeutic range | Detect altered anticoagulation; warfarin users only |
Cadence: Baseline measures; symptoms/intake at 1–2 weeks; weekly weight trends, monthly weight/waist; relevant blood tests at 12 weeks. Pragmatic, not trial-validated. Warfarin: prescriber-defined checks after changes. No thylakoid-specific laboratory target is established; practitioner ranges are not proven longevity targets.